[1]赵惠扬.甲胎蛋白放射免疫分析法的临床应用价值[J].国际放射医学核医学杂志,1978,2(1):28-34.
点击复制

甲胎蛋白放射免疫分析法的临床应用价值(/HTML)
分享到:

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
2
期数:
1978年第1期
页码:
28-34
栏目:
论文
出版日期:
1900-01-01

文章信息/Info

作者:
赵惠扬
上海中山医院同位素室
摘要:
甲胎蛋白(Alpha-l-Fetoprotein简称AFP)是一种正常的胎儿血清蛋白[1]。1944年Pederson等氏[2]首先在小牛血清中发现,但未引起重视。1966年Bergstrand等氏[1]用电泳法在人血清中查到有甲胎蛋白存在。1963年Abelev等氏[3]在小鼠移植性肝细胞癌中找到甲胎蛋白,它是正常小鼠肝组织中所没有的成份。1984年Tatarinov氏[4]证实肝癌患者血清中存

参考文献/References:

[1] Bergstrand C G和Czar B:Scandi-navian Journal of Clinical and La-boratory Investigation 8:174,1956
[2] Pederson K 0:Nature(Lond.)154:575, 1944.
[3] Abelev GI等:Transplantation,1:174-180, 1963.
[4] Tatarinov Y S:Vop,Med Khim 10:584, 1964.
[5] Gitlin D等:Cancer Research.32: 979~982,1972.
[6] CEA-IRE-SORIN:Kit for α-Feto-Protein radioimmunoassay (1975).
[7] Colloque Inserm Nice (France)7~9 mars,1974.
[8] Gitlin D和 Boesman M: Journal of clinical investigation.45:1826-1838, 1966.
[9] Seppala M和Ruoslahti E: Ameri-can Journal of obstetrics and Gy-necology,115:48~52, 1973.
[10] Ruoslahti E和Seppala M: Int, J. Cancer 8:374~383, 1971.
[11] Chayvialle J A P和Ganguli P C: Lancet 1:1355~1357, 1973.
[12] Maldmann T A McIntire KR:Lancet 11:1112~1115,1972.
[13] Rouslahti E和Sahpala M:Nature 236:161,1972.
[14] Purves LR et al:S Afr Med J 46: 1290, 1972.
[15] Purves L R and Geddes E W: La-ncet 1:47~48,1972.
[16] Bloomer J R等:Gastroenterology.65:530, 1973.
[17] Silver H K B; Gold P; Feder S; Freedman S O和Shuster J, Radioi-mmunoassay for human alpha-feto-protein,Proceedings of the National Academy of Sciences of the U.S.A,70:526~530, 1973.
[18] Kumimasa T等:核医学10:172, 1973,
[19] Tsutsui K等:核医学10:172, 1973.
[20] 户泽辰雄:肝脏14:302~314, 1973.
[21] 重田幸二郎:肝脏14: 506-516,1973.
[22] Silver HKB等:Cancer Res 34:244~247,1974.
[23] Waldmann T A and McIntire K R:Cancer 34:1510~1515, 1974.
[24] Ruoslahti H:Br Med J 11:527~529, 1974.
[25] Bloomer J R等:JAMA 233 :38~41,1975.
[26] Tonami N等:Cancer.36:466~470,1975.
[27] Chandra R K等:Br Med J 1:714~715,1975.
[28] Kew M:Gut 15:814~821,1974.
[29] Lorder J等:Lancet 1:1187,1973.
[30] Alpert E:Clin Gastroenterol 5:639~644,1976.
[31] Masopust J等:Int J Cancer 3: 364~375,1968.
[32] Belanger L等:L’ Union Médicale 101:877-878,1972.
[33] Waldmann T A等:Lancet 11:1112~1115,1972.
[34] Chandra R K等:Br Me J. 1:714-715, 1975.
[35] Alpert E等:Gastroenterology 61:144, 1971.
[36] Purees L R,et al:Serum alpha-fe-toprotein,1V Effects of chemother-apy and radiotherapy on serum al-pha-feto-protein levels in cases of primary livercancer.Year book Sufg.P.448,1971.
[37] Abelev G I:Adv Cancer Res 14: 295-357,1971.
[38] Hirai H等:Proteins in Biological Fluids,20:579-587,1973.
[39] AlPert E:Clinica Chimia Acta 58:77-83; 1975.
[40] Tsung S H: Arch Pathol 99:267-269, 1975,
[41] Zizkovsky; Gann 65:193,1974.
[42] Kurata K等:Radioimmunoassay of alpha-Fetoprotein. Radioimmu-assay and Related Procedares in Medicine. Proceeding of A Sym-posium, 1973,Vol.2, P.299-313.

更新日期/Last Update: 1900-01-01